A meeting was held at the Francis Crick Institute at 5pm on Thursday 31 October 2019, on the theme of NMR in Drug Discovery:
- Ben Davis (Vernalis UK): NMR in drug discovery and fragment-based lead discovery
- Gian De Nicola (King’s): p38α-TAB1 complex aggravates myocardial injury. Can we drug it?
- Teresa Almeida (NIBSC): NMR: a “solution” method to study ligand binding to EB1
The meeting concluded with informal discussions and drinks in the Crick bar.